The study found that for women with "triple-negative" breast cancer, adding Keytruda to standard chemotherapy improved their odds of responding.
https://ift.tt/2Pw9pjw
from WebMD Health https://ift.tt/32yBlbM
by
The study found that for women with "triple-negative" breast cancer, adding Keytruda to standard chemotherapy improved their odds of responding.
Comments
Post a Comment